GRAFONE, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 644
EU - Europa 488
AS - Asia 285
AF - Africa 30
SA - Sud America 2
OC - Oceania 1
Totale 1.450
Nazione #
US - Stati Uniti d'America 642
GB - Regno Unito 129
CN - Cina 89
SE - Svezia 88
JP - Giappone 73
DE - Germania 59
IT - Italia 54
UA - Ucraina 52
SG - Singapore 51
VN - Vietnam 37
IN - India 24
FR - Francia 22
RU - Federazione Russa 21
IE - Irlanda 18
TG - Togo 13
FI - Finlandia 12
EE - Estonia 9
BG - Bulgaria 7
ZA - Sudafrica 7
BE - Belgio 6
CI - Costa d'Avorio 5
NL - Olanda 5
JO - Giordania 4
SC - Seychelles 4
BD - Bangladesh 2
CA - Canada 2
CH - Svizzera 2
IR - Iran 2
LT - Lituania 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
ID - Indonesia 1
KR - Corea 1
LB - Libano 1
NG - Nigeria 1
Totale 1.450
Città #
Southend 109
Chandler 97
Tokyo 65
Fairfield 60
Ashburn 45
Singapore 39
Woodbridge 38
Jacksonville 36
Seattle 36
Wilmington 32
Houston 31
Santa Clara 31
Ann Arbor 24
Princeton 22
Cambridge 21
Dublin 18
Boardman 16
Lomé 13
Helsinki 12
Turin 12
Beijing 11
Padova 11
Westminster 11
Nanchang 10
Berlin 8
Nanjing 8
Brussels 6
New York 6
Saint Petersburg 6
Sofia 6
Abidjan 5
Taizhou 5
Amman 4
Chiyoda-ku 4
Jinan 4
Mahé 4
Milan 4
Mülheim 4
San Diego 4
Tianjin 4
Bologna 3
Falkenstein 3
Florence 3
Hamamatsu 3
Hebei 3
Lanzhou 3
Los Angeles 3
Medford 3
Rome 3
Shenyang 3
Bengaluru 2
Bremen 2
Des Moines 2
Dhaka 2
Hangzhou 2
Jiaxing 2
Moscow 2
Mountain View 2
Munich 2
Ningbo 2
Nuremberg 2
Olalla 2
Phoenix 2
Pune 2
Shanghai 2
Taiyuan 2
Tappahannock 2
Verona 2
Abeokuta 1
Amsterdam 1
Andover 1
Apo 1
Baoding 1
Buk-gu 1
Bühl 1
Changchun 1
Changsha 1
Frankfurt am Main 1
Groningen 1
Guangzhou 1
Haikou 1
Hefei 1
Jinhua 1
Kashan 1
Kawasaki 1
La Canada Flintridge 1
Lausanne 1
Muizenberg 1
Mumbai 1
Nanyang 1
Newark 1
Norwalk 1
Olinda 1
Redmond 1
Sacramento 1
San Jose 1
São Paulo 1
Torino 1
Toronto 1
Washington 1
Totale 980
Nome #
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies 206
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies 193
Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia. 132
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia. 131
Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells 130
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia 121
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 116
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 112
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 111
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. 110
Protein Tyrosine Phosphatase Receptor Type {gamma} Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 88
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC 24
Totale 1.474
Categoria #
all - tutte 3.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 0 0 0 31 13 20
2020/2021176 36 14 2 7 2 12 0 12 14 10 13 54
2021/2022215 8 2 18 25 16 16 7 10 5 23 35 50
2022/2023288 28 59 9 43 12 34 8 10 43 10 29 3
2023/2024143 5 12 1 5 10 59 21 13 3 3 6 5
2024/2025180 5 34 21 20 44 22 18 16 0 0 0 0
Totale 1.474